Cadrenal Therapeutics
CVKD
CVKD
2 hedge funds and large institutions have $68 invested in Cadrenal Therapeutics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.
Holders
2
Holders Change
-7
Holders Change %
-77.78%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Bank of America
Charlotte,
North Carolina
| $68 | 5 | -76 | -94% |
|
|
APP
2
Avantax Planning Partners
Dubuque,
Iowa
| – | – | -113,305 | Closed |
|
3
Geode Capital Management
Boston,
Massachusetts
| – | – | -61,554 | Closed |
|
4
Renaissance Technologies
New York
| – | – | -59,491 | Closed |
|
5
Citadel Advisors
Miami,
Florida
| – | – | -54,543 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | – | -24,737 | Closed |
|
|
TSS
7
Two Sigma Securities
New York
| – | – | -15,858 | Closed |
|
|
BFO
8
Biltmore Family Office
Charlotte,
North Carolina
| – | – | -11,000 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | – | -9,666 | Closed |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 25 | +25 | New |
|